- Home
- MGPI vs TERN Comparison
MGPI vs TERN Comparison
Compare MGPI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- TERN
- Stock Information
- Founded
- MGPI 1941
- TERN 2017
- Country
- MGPI United States
- TERN United States
- Employees
- MGPI N/A
- TERN N/A
- Industry
- MGPI Beverages (Production/Distribution)
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- TERN Health Care
- Exchange
- MGPI Nasdaq
- TERN Nasdaq
- Market Cap
- MGPI 610.9M
- TERN 634.5M
- IPO Year
- MGPI 1988
- TERN 2021
- Fundamental
- Price
- MGPI $27.57
- TERN $7.40
- Analyst Decision
- MGPI Strong Buy
- TERN Buy
- Analyst Count
- MGPI 5
- TERN 6
- Target Price
- MGPI $45.40
- TERN $13.99
- AVG Volume (30 Days)
- MGPI 186.0K
- TERN 1.1M
- Earning Date
- MGPI 10-30-2025
- TERN 11-11-2025
- Dividend Yield
- MGPI 1.75%
- TERN N/A
- EPS Growth
- MGPI N/A
- TERN N/A
- EPS
- MGPI N/A
- TERN N/A
- Revenue
- MGPI $609,404,000.00
- TERN N/A
- Revenue This Year
- MGPI N/A
- TERN N/A
- Revenue Next Year
- MGPI N/A
- TERN N/A
- P/E Ratio
- MGPI N/A
- TERN N/A
- Revenue Growth
- MGPI N/A
- TERN N/A
- 52 Week Low
- MGPI $25.12
- TERN $1.87
- 52 Week High
- MGPI $86.35
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- MGPI 40.60
- TERN 59.10
- Support Level
- MGPI $27.50
- TERN $7.01
- Resistance Level
- MGPI $28.45
- TERN $7.67
- Average True Range (ATR)
- MGPI 0.81
- TERN 0.42
- MACD
- MGPI -0.12
- TERN -0.06
- Stochastic Oscillator
- MGPI 7.84
- TERN 62.00
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.